Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Figma Inc. Class A Common Stock (FIG) vs Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN) Price & Performance

Figma Inc. Class A Common StockTrade
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)Trade

Price performance (Past 24H)

Key statistics

Figma Inc. Class A Common Stock vs Haleon plc American Depositary Shares (Each representing two Ordinary Shares) — how do they compare? Figma Inc. Class A Common Stock trades at $21.23 (market cap $11.60B), while Haleon plc American Depositary Shares (Each representing two Ordinary Shares) trades at $9.69 (market cap $41.25B). The key difference: Haleon plc American Depositary Shares (Each representing two Ordinary Shares) is far larger — about 3.6× Figma Inc. Class A Common Stock's market cap, and Haleon plc American Depositary Shares (Each representing two Ordinary Shares) pays a 2.1% dividend while Figma Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Figma Inc. Class A Common Stock for 0 Days and Haleon plc American Depositary Shares (Each representing two Ordinary Shares) for 3 Days on average.

FIGHLN
Market Cap
$11.60B$41.25B
Volume
12,281,01313,519,869
Sector
TechnologyHealth
52-Week High
$63.82$11.27
52-Week Low
$16.84$8.70
Typical Hold Time
0 Days3 Days
Enterprise Value
$10.00B$51.03B
Dividend Yield
—2.1%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Figma Inc. Class A Common Stock

No Aura AI signal available yet.

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon (HLN) trades at $9.44, down 0.63% today, with strong technical momentum showing a bullish moving average signal. The company demonstrates robust fundamentals with $11.03B revenue, 14.55% net margin, and consistent earnings beats in recent quarters. Recent business developments include successful shelf space negotiations with major retailers and growth from weight-loss drug side-effect products.

The outlook remains positive with 75% analyst buy ratings and improving cash flow projections for 2026. Key opportunities include market share gains and margin expansion, while risks involve competitive pressures and potential margin compression. The stock presents a balanced risk-reward profile for investors seeking exposure to consumer healthcare.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FIG
100% Buy0% Sell
Avg holding period · 0 Days
HLN

No sentiment data available yet.

About Figma Inc. Class A Common Stock

Figma, Inc. is a US software company that operates a collaborative interface design and product development platform used by design and engineering teams to create, prototype, and build digital products.

Read more on FIG →

About Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon is a consumer healthcare company offering over-the-counter medicines, oral health products, vitamins, and wellness brands.

Read more on HLN →